Anaphylaxis: A Primer for Injectors
This program will support all pharmacy team members to guide them in assisting patients in the proper choice of and use of auto-injectors.
$50.00
Description
Description:
Anaphylaxis is a serious medical emergency where symptoms can develop within minutes or gradually over a few hours. It is essential that pharmacy team members are prepared and can act quickly if a patient has symptoms.
This program will discuss best practices on how to ensure patients and caregivers have the appropriate delivery and understand how to properly use an epinephrine auto-injector. Plus, participants will receive a case study walk-through and will learn more about the causes, symptoms, and various treatments for anaphylaxis.
Learning Objectives:
By the end of this course, you should be able to:
- Discuss the pathophysiology, causes and risk factors for anaphylaxis
- Describe the symptoms associated with anaphylaxis
- Describe the current therapies available, role of current therapies and rationale for product/dose selection
- Provide patient education regarding anaphylaxis including how to recognize symptoms, trigger avoidance and correct use of an epinephrine auto-injector
Course Outline:
-
Online Module (0.75 hours)
-
Multiple-choice Exam
-
Program Evaluation
Sponsor:
Previously sponsored by Bausch Health.
Course at a Glance:
- 0.75 hour to complete
- Course expiry date: February 21, 2025
- Online
- Accreditation: This course is unaccredited.
- Completion requirement: Complete the online modules, multiple-choice exam (with a score of 70 per cent or higher) and the program evaluation before the expiry date to receive a letter of completion.
Who Should Take This Course:
Pharmacists and pharmacy technicians who want to be better prepared to assist patients who experience anaphylaxis.
Development Team:
- Sandra Knowles, BSc Phm
- Roxanne Hook, BSc Phm, M.Ed.
- Sherilyn Houle, BSc Phm, PhD
- Mike Yake, BSc Phm
Cancelation Policy:
Please refer to OPA’s Terms and Conditions of Purchase for cancellation policies.